Nitric Oxide-Releasing Polymers Containing the [N(O)NO]-Group
- 1 January 1996
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 39 (5) , 1148-1156
- https://doi.org/10.1021/jm950652b
Abstract
Ions of structure X[N(O)NO]- display broad-spectrum pharmacological activity that correlates with the rate and extent of their spontaneous, first-order decomposition to nitric oxide when dissolved. We report incorporation of this functional group into polymeric matrices that can be used for altering the time course of nitric oxide release and/or targeting it to tissues with which the polymers are in physical contact. Structural types prepared include those in which the [N(O)NO]- group is attached to heteroatoms in low molecular weight species that are noncovalently distributed throughout the polymeric matrix, in groupings pendant to the polymer backbone, and in the polymer backbone itself. They range in physical form from films that can be coated onto other surfaces to microspheres, gels, powders, and moldable resins. Chemiluminescence measurements confirm that polymers to which the [N(O)NO]- group is attached can serve as localized sources of nitric oxide, with one prototype providing sustained NO release for 5 weeks in pH 7.4 buffer at 37 °C. The latter composition, a cross-linked poly(ethylenimine) that had been exposed to NO, inhibited the in vitro proliferation of rat aorta smooth muscle cells when added as a powder to the culture medium and showed potent antiplatelet activity when coated on a normally thrombogenic vascular graft situated in an arteriovenous shunt in a baboon's circulatory system. The results suggest that polymers containing the [N(O)NO]- functional group may hold considerable promise for a variety of biomedical applications in which local delivery of NO is desired.Keywords
This publication has 23 references indexed in Scilit:
- TISSUE ENGINEERINGChemical & Engineering News, 1995
- DNA Sequence Changes Induced by Two Nitric Oxide Donor Drugs in the supF AssayChemical Research in Toxicology, 1994
- Animal models of restenosisTrends in Cardiovascular Medicine, 1994
- Complexes of Nitric Oxide with Nucleophiles as Agents for the Controlled Biological Release of Nitric OxideJournal of Cardiovascular Pharmacology, 1993
- Mechanism of Vascular Relaxation Induced by the Nitric Oxide (NO)/Nucleophile Complexes, a New Class of NO-Based VasodilatorsJournal of Cardiovascular Pharmacology, 1993
- Exogenous nitric oxide inhibits in vivo platelet adhesion following balloon angioplastyCardiovascular Research, 1992
- Prediction of a Crystallization Pathway for Z-DNA HexanucleotidesScience, 1991
- Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- Stability of the Chloro-complexes of Iodine in Aqueous Solution1Journal of the American Chemical Society, 1961
- The Reaction of Nitrogen(II) Oxide with DiethylamineJournal of the American Chemical Society, 1960